InvestorsHub Logo
Followers 6
Posts 3891
Boards Moderated 0
Alias Born 01/14/2001

Re: ann441j post# 79318

Tuesday, 09/09/2008 1:26:47 PM

Tuesday, September 09, 2008 1:26:47 PM

Post# of 82595
"Dear Patrons,
You may have seen the press release announcing the merger of ReliaGene Technologies, Inc. and Orchid Cellmark, Inc. We are very excited about the alliance, but we know your initial question will probably be �how will this affect me?� Rest assured that we intend to continue to provide you with the level of service you have come to expect from ReliaGene. We want this change to be as seamless and transparent as possible, meaning our laboratory operations, customer services and reporting will be unchanged in the near term.

Orchid is the oldest and most experienced company in the human identity testing field and services clients in both the forensic and paternity markets. Their U.K. lab, in addition to human identity testing, also serves the agricultural community with testing for selective trait breeding. Orchid has four labs in the U.S.- two forensic and two paternity, and employs a highly experienced and respected scientific staff. Orchid scientists have testified in over 2000 cases in all fifty states.

We believe this merger of two of the largest and most experienced DNA labs in the country will enable us to provide you with unparalleled service and will give us the resources to meet your growing needs. As we integrate our two companies, we will welcome your comments to let us know how we are doing.

Thank you for your ongoing support.

Sincerely,

Sudhir K. Sinha, Ph.D.
President and Laboratory Director
ReliaGene Technologies, Inc."

Ann